BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21820154)

  • 1. Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival.
    Arriaga JM; Levy EM; Bravo AI; Bayo SM; Amat M; Aris M; Hannois A; Bruno L; Roberti MP; Loria FS; Pairola A; Huertas E; Mordoh J; Bianchini M
    Hum Pathol; 2012 Feb; 43(2):197-208. PubMed ID: 21820154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
    Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
    Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
    Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
    Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of activator protein-4 in human colorectal cancer with metastasis.
    Cao J; Tang M; Li WL; Xie J; Du H; Tang WB; Wang H; Chen XW; Xiao H; Li Y
    Int J Surg Pathol; 2009 Feb; 17(1):16-21. PubMed ID: 18480385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
    J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
    Boltze C
    Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
    Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
    Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
    Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
    BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of metallothionein in human gastrointestinal cancer.
    Janssen AM; van Duijn W; Kubben FJ; Griffioen G; Lamers CB; van Krieken JH; van de Velde CJ; Verspaget HW
    Clin Cancer Res; 2002 Jun; 8(6):1889-96. PubMed ID: 12060633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.